Abnormalities on the multifocal electroretingram may precede clinical signs of hydroxychloroquine retinotoxicity [12]

Eye

Volumn 20, Issue 1, 2006, Pages 129-132

  Teoh, Stephen C B ^a   Lim, J ^a   Koh, A ^a   Lim, T ^a   Fu, E ^a  

^a TAN TOCK SENG HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPENTOLATE; HYDROXYCHLOROQUINE; PHENYLEPHRINE; PROXYMETACAINE; ANTIRHEUMATIC AGENT;

ADULT; CASE REPORT; CORNEA; DISEASE COURSE; DRUG WITHDRAWAL; ELECTRORETINOGRAM; EYE MOVEMENT; EYE TOXICITY; FEMALE; HUMAN; INTRAOCULAR PRESSURE; LETTER; MYDRIASIS; PERIMETRY; RECORDING; REFRACTION ERROR; RETINA DISEASE; RHEUMATOID ARTHRITIS; SENSORY SYSTEM ELECTROPHYSIOLOGY; VISUAL ACUITY; VISUAL DISORDER; VISUAL FIELD DEFECT; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; ELECTRORETINOGRAPHY; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; RETINA; SCOTOMA; STANDARD; TIME; VISION TEST;

ANTIRHEUMATIC AGENTS; ELECTRORETINOGRAPHY; FEMALE; HUMANS; HYDROXYCHLOROQUINE; MIDDLE AGED; RETINA; SCOTOMA; TIME FACTORS; VISION SCREENING;

EID: 30744469905     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/sj.eye.6701818     Document Type: Letter

References (22)

1. Falcone PM, Paolini L, Lou PL. Hydroxychloroquine toxicity despite normal dose therapy. Ann Ophthalmol 1993; 25: 385-388.
2. Mavrikakis M, Papazoglou S, Sfikakis PF, Vaiopoulos G, Rougas K. Retinal toxicity in long term hydroxychloroquine treatment. Ann Rheum Dis 1996; 55: 187-189.
3. Weiner A, Sandberg MA, Gaudio AR, Kini MM, Berson EL. Hydroxychloroquine retinopathy. Am J Ophthalmol 1991; 112: 528-534.
4. Thorne JE, Maguire AM. Retinopathy after long term, standard doses of hydroxychloroquine. Br J Ophthalmol 1999; 83: 1201-1202.
5. Bienfang D, Coblyn JS, Liang MH, Corzillus M. Hydroxychloroquine retinopathy despite regular ophthalmology evaluation: A consecutive series. J Rheumatol 2000; 27: 2703-2706.
6. Warner AE. Early hydroxychloroquine macular toxicity. Arthritis Rheum 2001; 44: 1959-1961.
7. Levy GD, Munz SJ, Paschal J, Cohen HB, Pince KJ, Peterson T. Incidence of hydroxychloroquine retinopathy in 1,207 patients in a large multicenter outpatient practice. Arthritis Rheum 1997; 40: 1482-1486.
8. Bernstein HN. Ophthalmologic considerations and testing in patients receiving long-term anti-malarial therapy. Am J Med 1983; 75: 25-34.
9. Easterbrook M. Editorial: Current concepts in monitoring patients on antimalarials. Aust NZ J Ophthalmol 1998; 26: 101-103.
10. Fielder A, Graham E, Tullo A. Royal college of ophthalmologists guidelines: Ocular toxicity and hydroxychloroquine. Eye 1998; 12: 907-909.
11. Mavrikakis I, Sfikakis PF, Mavrikakis E, Rougas K, Nikolaou A, Kostopoutos C et al. The incidence of irreversible retinal toxicity in patients treated with hydroxychloroquine: A reappraisal. Ophthalmology 2003; 110: 1321-1326.
12. Penrose PJ, Tzekov RT, Sutter EE, Fu AD, Allen Jr AW, Fung WE et al. Multifocal electroretinography evaluation for early detection of retinal dysfunction in patients taking hydroxychloroquine. Retina 2003; 23: 503-512.
13. Marmor MF, Carr RE, Easterbrook M, Farjo AA, Mieler WF, American Academy of Ophthalmology. Recommendations on screening for chloroquine and hydroxychloroquine retinopathy: A report by the AAO. Ophthalmology 2002; 109: 1377-1382.
14. Mackenzie AH. Dose refinement in long-term therapy of rheumatoid arthritis with antimalarials. Am J Med 1983; 75: 40-47.
15. Easterbrook M. Long-term course of anti-malarial maculopathy after cessation of treatment. Can J Ophthalmol 1992; 27: 237-239.
16. Tzekov RT, Serrato A, Marmor MF. ERG findings in patients using hydroxychloroquine. Doc Ophthalmol 2004; 108: 87-97.
17. Maturi RK, Yu M, Weleber RG. Multifocal electroretinographic evaluation of long-term hydroxychloroquine users. Arch Ophthalmol 2004; 122: 973-981.
18. Kellner U, Kraus H, Forester MH. Multifocal ERG in chloroquine retinopathy: Regional variance of retinal dysfunction. Graefes Arch Clin Exp Ophthalmol 2000; 238: 94-97.
19. Moschos MN, Moschos MM, Apostolopoulous M, Mallias JA, Bouros C, Theodossiadis GP. Assessing hydroxychloroquine toxicity by the multifocal ERG. Doc Ophthalmol 2004; 108: 47-53.
20. Easterbrook M. The sensitivity of amsler grid testing in early chloroquine retinopathy. Trans Ophthalmol Soc UK 1985; 104: 204-207.
21. Vu LBL, Easterbrook M, Hovis JK. Detection of color vision defects in chloroquine retinopathy. Ophthalmology 1999; 106: 1799-1804.
22. Easterbrook M. Detection and prevention of maculopathy associated with antimalarial agents. Int Ophthalmol Clin 1999; 39: 49-57.